Page last updated: 2024-08-21

pyrazines and POEMS Syndrome

pyrazines has been researched along with POEMS Syndrome in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (6.67)29.6817
2010's14 (93.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hou, L; Liu, T; Liu, ZG; Niu, T; Yang, JR; Yang, YM; Zeng, K1
Hagihara, M; Hattori, Y; Ishigatsubo, Y; Ishii, Y; Ishiyama, Y; Tomita, N; Yamamoto, E; Yamazaki, E1
Creamer, A; Gaastra, B; Odogwu, S; Whitelaw, B1
Alonso Vence, N; Bello Lopez, JL; BendaƱa Lopez, A; Diaz Arias, J; Fraga Rodriguez, M; Sobas, MA1
Gu, B; Liu, Y; Qiu, H; Ruan, C; Shi, X; Sun, A; Tang, X; Wu, D; Xue, S; Zhou, H1
Bayik, M; Cetiner, M; Kaygusuz, I; Kocakaya, O; Tezcan, H; Uzay, A1
Fukuhara, N; Harigae, H; Ichinohasama, R; Ishizawa, K; Ohba, R; Ohguchi, H; Okitsu, Y; Onishi, Y; Yamamoto, J1
Gao, J; Wang, X; Xiao, C; Xing, X; Xiong, C; Ye, S1
Albrecht, P; Braun, SA; Hanneken, S; Methner, A1
Kuwabara, S1
Li, LH; Tang, XW; Zhang, R1
Dispenzieri, A; Kohut, IE; Warsame, R1
Cao, XX; Duan, MH; Kang, WY; Li, J; Zhang, W; Zhou, DB1
Li, J; Liu, T; Niu, T; Wei, Q; Yang, JR; Yang, YM; Zeng, K1
Li, J; Zhou, DB1

Reviews

4 review(s) available for pyrazines and POEMS Syndrome

ArticleYear
[Treatment for POEMS syndrome with subcutaneous administration of bortezomib followed by autologous peripheral blood stem cell transplantation: a case report and literatures review].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2013, Volume: 34, Issue:6

    Topics: Boronic Acids; Bortezomib; Humans; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; POEMS Syndrome; Pyrazines; Transplantation, Autologous

2013
[New treatment strategy for Crow-Fukase (POEMS) syndrome].
    Rinsho shinkeigaku = Clinical neurology, 2010, Volume: 50, Issue:11

    Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Boronic Acids; Bortezomib; Combined Modality Therapy; Demyelinating Diseases; Humans; Lenalidomide; Melphalan; Peripheral Blood Stem Cell Transplantation; POEMS Syndrome; Pyrazines; Thalidomide; Transplantation, Autologous; Vascular Endothelial Growth Factor A

2010
Effective induction therapy with subcutaneous administration of bortezomib for newly diagnosed POEMS syndrome: a case report and a review of the literature.
    Acta haematologica, 2013, Volume: 129, Issue:2

    Topics: Administration, Oral; Boronic Acids; Bortezomib; Dexamethasone; Humans; Injections, Subcutaneous; Male; Middle Aged; Neoadjuvant Therapy; POEMS Syndrome; Pyrazines; Remission Induction

2013
New advances in the diagnosis and treatment of POEMS syndrome.
    British journal of haematology, 2013, Volume: 161, Issue:3

    Topics: Antibodies, Monoclonal, Humanized; Bevacizumab; Boronic Acids; Bortezomib; Castleman Disease; Chromosome Aberrations; Combined Modality Therapy; Dexamethasone; Disease Management; Drug Therapy, Combination; Genes, Immunoglobulin; Humans; Hypertension, Pulmonary; Lenalidomide; Melphalan; Osteosclerosis; Peripheral Blood Stem Cell Transplantation; Plasma Cells; POEMS Syndrome; Prognosis; Pyrazines; Severity of Illness Index; Symptom Assessment; Thalidomide; Transplantation, Autologous; Vascular Endothelial Growth Factor A

2013

Other Studies

11 other study(ies) available for pyrazines and POEMS Syndrome

ArticleYear
Successful treatment of POEMS syndrome with bortezomib and dexamethasone, combined with radiotherapy, and followed by autologous stem cell transplantation.
    International journal of hematology, 2013, Volume: 98, Issue:6

    Topics: Adult; Boronic Acids; Bortezomib; Dexamethasone; Drug Therapy, Combination; Female; Hematopoietic Stem Cell Transplantation; Humans; POEMS Syndrome; Positron-Emission Tomography; Pyrazines; Radiotherapy; Tomography Scanners, X-Ray Computed; Transplantation, Autologous; Treatment Outcome

2013
POEMS syndrome: a challenging diagnosis of a rare disease.
    British journal of hospital medicine (London, England : 2005), 2014, Volume: 75, Issue:7

    Topics: Adult; Antineoplastic Agents; Boronic Acids; Bortezomib; Cyclophosphamide; Dexamethasone; Diagnosis, Differential; Drug Therapy, Combination; Humans; Male; POEMS Syndrome; Pyrazines; Rare Diseases

2014
Efficacy of bortezomib in refractory form of multicentric Castleman disease associated to poems syndrome (MCD-POEMS variant).
    Annals of hematology, 2010, Volume: 89, Issue:2

    Topics: Boronic Acids; Bortezomib; Castleman Disease; Humans; Male; Middle Aged; POEMS Syndrome; Protease Inhibitors; Pyrazines; Treatment Outcome

2010
Successful bortezomib-based treatment in POEMS syndrome.
    European journal of haematology, 2009, Dec-01, Volume: 83, Issue:6

    Topics: Adult; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Cyclophosphamide; Cytarabine; Depression, Chemical; Dexamethasone; Doxorubicin; Drug Therapy, Combination; Humans; Male; Melphalan; Plasma Cells; POEMS Syndrome; Prednisone; Protease Inhibitors; Pyrazines; Remission Induction; Vascular Endothelial Growth Factor A; Vincristine

2009
Bortezomib: a new therapeutic option for POEMS syndrome.
    European journal of haematology, 2010, Feb-01, Volume: 84, Issue:2

    Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Glycoproteins; Humans; Male; POEMS Syndrome; Pyrazines; Remission Induction

2010
Successful treatment with bortezomib and thalidomide for POEMS syndrome.
    Annals of hematology, 2011, Volume: 90, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Female; Humans; Middle Aged; POEMS Syndrome; Pyrazines; Radionuclide Imaging; Remission Induction; Thalidomide; Treatment Outcome

2011
Successful treatment with bortezomib and thalidomide for POEMS syndrome associated with multicentric mixed-type Castleman's disease.
    Japanese journal of clinical oncology, 2011, Volume: 41, Issue:10

    Topics: Adult; Angiogenesis Inhibitors; Boronic Acids; Bortezomib; Castleman Disease; Drug Therapy, Combination; Humans; Male; POEMS Syndrome; Pyrazines; Thalidomide; Vascular Endothelial Growth Factor A

2011
[POEMS syndrome. An interdisciplinary clinical challenge].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2011, Volume: 62, Issue:10

    Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Boronic Acids; Bortezomib; Cooperative Behavior; Dexamethasone; Drug Therapy, Combination; Humans; Immunoglobulin lambda-Chains; Interdisciplinary Communication; Male; Middle Aged; Paraproteinemias; POEMS Syndrome; Pyrazines; Vascular Endothelial Growth Factor A

2011
[Autologous hematopoietic stem cell transplantation following bortezomib-based chemotherapy for one case with POEMS syndrome].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2011, Volume: 32, Issue:11

    Topics: Adult; Boronic Acids; Bortezomib; Combined Modality Therapy; Female; Hematopoietic Stem Cell Transplantation; Humans; POEMS Syndrome; Pyrazines

2011
Successful use of cyclophosphamide, bortezomib, and dexamethasone to treat a case of relapsed POEMS.
    European journal of haematology, 2012, Volume: 88, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Cyclophosphamide; Dexamethasone; Humans; Male; Paraneoplastic Syndromes; POEMS Syndrome; Pyrazines; Recurrence

2012
Bortezomib and dexamethasone as first-line therapy for a patient with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes syndrome complicated by renal failure.
    Leukemia & lymphoma, 2012, Volume: 53, Issue:12

    Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Boronic Acids; Bortezomib; Dexamethasone; Drug Therapy, Combination; Humans; Induction Chemotherapy; Male; Middle Aged; POEMS Syndrome; Pyrazines; Renal Insufficiency; Treatment Outcome

2012